$INND InnerScope Hearing Technologies (OTC: INND) Launches

New Post Public Reply Private Reply Replies (0) Message Board

Aug 3, 2023 at 9:00 AM 239

$INND InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of OTC Rechargeable Hearing Aids on Walgreens.com

InnerScope Hearing Technologies (OTC: INND) Launches HearingAssist Brand of OTC Rechargeable Hearing Aids on Walgreens.com

InnerScope Continues its B2B Major Retailer Sales Growth Strategy and Strengthens its Market Penetration With The Launch of Its OTC Hearing Aids On Walgreens.com

ROSEVILLE, Calif., April 5, 2023 /PRNewswire/ -- InnerScope Hearing Technologies Inc. (OTC: INND) ("InnerScope"

, an emerging and disruptive leader in the Over-the-Counter (OTC) Hearing Aid category, today announced the launch of its HearingAssist brand FDA-Registered Over-the-Counter ("OTC"

Rechargeable Hearing Aids ("HearingAssist Rechargeable OTC Hearing Aids"

including its EZHear Neckband Amplifier and other assorted HearingAssist branded hearing and hearing related supplies ("HearingAssist Hearing Products"

on Walgreens.com.

InnerScope's HearingAssist brand, with over 500,000 hearing aids sold, is fast becoming America's #1 Brand of OTC Hearing Aids. This latest launch of HearingAssist Rechargeable OTC Hearing Aids and HearingAssist Hearing Products on Walgreens.com gives InnerScope nationwide access to Walgreens customers dealing with hearing loss and struggling to find affordable, high-quality hearing aids.

"InnerScope continues to execute on its successful B2B sales growth strategy with this latest HearingAssist launch on Walgreens.com, said Matthew Moore, President and CEO of InnerScope Hearing Technologies. "Walgreens customers can now enjoy the premium rich hearing features offered in the HearingAssit OTC Rechargeable Hearing Aids with prices starting at $499 to $799 a pair compared to similar hearing aids with the same features for thousands of dollars more. With hundreds of thousands of satisfied customers, HearingAssist is America's #1 Brand of OTC Hearing Aids. Furthermore, InnerScope, with its HearingAssist and iHEAR brands of OTC Hearing Aids, continues to dominate the OTC market with more wholesale distribution and market penetration than any other OTC hearing aid competitor."

HearingAssist Brand of affordable, high-quality OTC hearing aids is now available on Walgreens.com. Walgreens customers can purchase HearingAssist OTC Rechargeable Hearing Aids without a hearing exam or prescription or need to see a hearing health professional for fitting. HearingAssist OTC Rechargeable Hearing Aids are priced from $499 to $799 a pair and work great right out of the box. However, for customers who would like assistance adjusting the devices to their specific listening needs, HearingAssist's call center has a team of Doctors of Audiology and Licenced Hearing Professionals who will help adjust the devices to get the maximum hearing benefit in every listening environment.

HearingAssist OTC Rechargeable Hearing Aids have the latest in hearing technology features that include Bluetooth® wireless app-controlled models that allow full audio streaming using a smartphone for hands-free phone calling and listening to music or podcasts. As a result, HearingAssist OTC Rechargeable Hearing Aids deliver a clear and crisp sound for understanding conversations on the phone, in a group setting, or in a noisy environment. Moreover, HearingAssist OTC Rechargeable Hearing Aids have the same high-end hearing technology features (full wireless audio streaming, direction microphones, noise reduction algorithms, and environmental programs) as hearing aids sold and fit by hearing healthcare professionals for as much as $5,000 a pair or more.

HearingAssist OTC Rechargeable Hearing Aids offered on Walgreens.com:

Please Click on the Links for More Info:

Hearing Assist Stream RIC Rechargeable Hearing Aid Kit Pair Gray | Walgreens

Hearing Assist Control RIC Rechargeable Hearing Aid Kit Pair Silver | Walgreens

Hearing Assist Connect ITE Rechargeable Hearing Aid Kit Pair White | Walgreens

Hearing Assist Eaze RIC Rechargeable Hearing Aid Kit Pair Champagne | Walgreens

Please Click the Link to access the complete page with all four HearingAssist OTC Rechargeable Hearing Aids models, including its EZHear Neckband Amplifier and other assorted hearing and hearing-related supplies: Hearing Assist | Walgreens

About Walgreens:
Walgreens (www.walgreens.com) is included in the U.S. Retail Pharmacy and U.S. Healthcare segments of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), an integrated healthcare, pharmacy, and retail leader with a 170-year heritage of caring for communities. WBA's purpose is to create more joyful lives through better health. With nearly 9,000 retail locations across America, Puerto Rico, and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers daily. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services, including those that drive equitable access to care for the nation's medically underserved populations. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.

About InnerScope Hearing Technologies, Inc. (OTC PINK: INND):
InnerScope Hearing Technologies Inc. is a manufacturer and distributor of OTC Hearing Aids, Hearing Aid Accessories & Hearing Health-Related Products ("Hearing Products"

dedicated to addressing the global demand for affordable hearing solutions. InnerScope's, with its B2B business distribution model offering affordable OTC Hearing Products through major retailers, pharmacy chains, and healthcare service companies, breaks through the barriers that prevent access to effective and affordable hearing solutions.

In September 2021, InnerScope acquired iHear Medical Inc., a Direct-to-Consumer ("DTC"

cloud-based hearing solution provider, which provided access to over 40 patents and an R&D facility, and a team of engineers. In addition, InnerScope, in November 2021, also acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced and affordable Hearing Products through Walmart and many other major retailers and pharmacy chains.

InnerScope's full line of its HearingAssist and iHEAR branded Hearing Products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, Walgreens.com, RiteAid.com, Target.com, BestBuy.com, Amazon.com, AmerisourceBergen, Cardinal Health, Cardinal Health™ at-Home, Carewell.com FSAStore.com, HSAStore.com, WellDeservedHealth.com, Fingerhut.com, Giant Eagle / Hy-Vee / Hartig Drug / Food City / Wakefern Food Corp. / ShopRite / SpartanNash / VG's Grocery / Family Fare / Martin's Super Markets / Kholl's Pharmacy & Homecare and Topco Associates representing 15,000+ store locations.

Coming Soon: More major retailers and pharmacy chains for in-store and online HearingAssist and iHEAR branded Hearing Products.

For information related to InnerScope Hearing Technologies' latest hearing aids and related hearing products, please visit:
http://iheardirect.com
http://hearingassist.com

For the most up-to-date information about InnerScope Hearing Technologies (OTC: INND), please visit and follow our official Twitter account @inndstock page:
https://twitter.com/inndstock

InnerScope Hyperlinks:
HearingAssist - Website
HearingAssist - Walmart.com
HearingAssist - CVS.com
HearingAssist - Walgreens
HearingAssist - RiteAid.com
HearingAssist – Target.com
HearingAssist - BestBuy.com

iHEAR
iHEAR - CVS.com
AmerisourceBergen, Cardinal Health, Cardinal Health™ at-Home, Carewell.com FSAStore.com, HSAStore.com, WellDeservedHealth.com, Fingerhut.com, Giant Eagle / Hy-Vee / Hartig Drug / Food City / Wakefern Food Corp. / ShopRite / SpartanNash / VG's Grocery / Family Fare / Martin's Super Markets / Kholl's Pharmacy & Homecare, Topco Associates

Acquisition of iHear Medical Inc.
Acquisition of HearingAssist

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Innovent's SINTBILO® Hits Primary Endpoint in Study

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Cultural Tech Fusion: The Asia-Pacific Way Forward

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...